Janice Miller

Janice Miller is an experienced leader in pharmacovigilance, currently serving as Vice President and Head of North America Pharmacovigilance at Bayer since January 2023, responsible for strategic direction and medical guidance in the region. Previously, Janice held the position of Executive Director of Pharmacovigilance Medical Review and Device Safety at Organon and worked as a Global Safety Medical Director at Amgen. Janice's extensive background includes roles such as Director of Medical Safety Officer for Neurology at Johnson & Johnson, Senior Medical Director at Barrier Therapeutics, and Therapeutic Area Safety Head for Neuroscience at Janssen Inc./Johnson & Johnson. Educational qualifications include a Bachelor’s Degree in Biology from Rutgers University-New Brunswick, a Doctor of Medicine from the University of Medicine and Dentistry of New Jersey, a Family Practice board certification from Overlook Hospital, and an Executive MBA from Washington State University.